Hologic holders put $63.34 million 2% convertibles; remainder called

By Susanna Moon

Chicago, Dec. 13 - Hologic, Inc. said holders put $63,337,000 of its $405 million outstanding 2% convertible senior notes due 2037 for repurchase at par plus accrued interest on Dec. 13.

The company paid $63,970,370 to settle the put option, which expired at midnight ET on Dec. 12.

After settlement, there is $341,663,000 of the convertibles outstanding.

The company called the remaining notes for redemption on Dec. 18 at par plus accrued interest to but excluding the redemption date.

As announced in Nov. 14, the notes are convertible until 5 p.m. ET on Dec. 17 at a conversion rate of 25.911 shares per $1,000 principal amount outstanding, equal to a conversion price of about $38.59 per share.

The company's stock (Nasdaq: HOLX) closed at $20.59 on Nov. 13.

Wilmington Trust Co. (attn.: Sam Hamed, 302 636-6181, fax 302 636-4139, or email shamed@wilmingtontrust.com) was the trustee, paying agent and conversion agent.

Hologic is a Bedford, Mass.-based provider of diagnostics products, medical imaging systems and surgical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.